Milestone Pharmaceuticals Inc. (MIST) stock
MISTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.41+0.05 (+13.21%)
Close on Nov 17, 2026Market cap $51.44MP/E –Yield –
Milestone Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Milestone Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$61.29M. For fiscal 2025 it was -$49.04M. The highest annual figure on record is -$21.05M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$49.04M | – |
| FY2024 | Dec 31, 2024 | -$28.85M | – |
| FY2023 | Dec 31, 2023 | -$46.42M | – |
| FY2022 | Dec 31, 2022 | -$52.47M | – |
| FY2021 | Dec 31, 2021 | -$33.22M | – |
| FY2020 | Dec 31, 2020 | -$50.73M | – |
| FY2019 | Dec 31, 2019 | -$51.15M | – |
| FY2018 | Dec 31, 2018 | -$21.05M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$22.71M | – |
| Q1 FY2026 | Mar 31, 2026 | -$16.05M | – |
| Q4 FY2025 | Dec 31, 2025 | -$12.78M | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.75M | – |
| Q2 FY2025 | Jun 30, 2025 | -$12.57M | – |
| Q1 FY2025 | Mar 31, 2025 | -$13.95M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.84M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.02M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.05M | – |
| Q1 FY2024 | Mar 31, 2024 | -$8.93M | – |
| Q4 FY2023 | Dec 31, 2023 | -$9.80M | – |
| Q3 FY2023 | Sep 30, 2023 | -$12.16M | – |
| Q2 FY2023 | Jun 30, 2023 | -$10.56M | – |
| Q1 FY2023 | Mar 31, 2023 | -$13.90M | – |
| Q4 FY2022 | Dec 31, 2022 | -$12.86M | – |
| Q3 FY2022 | Sep 30, 2022 | -$11.57M | – |
| Q2 FY2022 | Jun 30, 2022 | -$14.09M | -1487.7% |
| Q1 FY2022 | Mar 31, 2022 | -$13.95M | – |
| Q4 FY2021 | Dec 31, 2021 | -$12.38M | – |
| Q3 FY2021 | Sep 30, 2021 | -$9.39M | – |
| Q2 FY2021 | Jun 30, 2021 | $1.02M | – |
| Q1 FY2021 | Mar 31, 2021 | -$12.47M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.76M | – |
| Q3 FY2020 | Sep 30, 2020 | -$7.33M | – |
| Q2 FY2020 | Jun 30, 2020 | -$16.56M | – |
| Q1 FY2020 | Mar 31, 2020 | -$18.08M | – |
| Q4 FY2019 | Dec 31, 2019 | -$16.60M | – |
| Q3 FY2019 | Sep 30, 2019 | -$8.30M | – |
| Q2 FY2019 | Jun 30, 2019 | -$11.52M | – |
| Q1 FY2019 | Mar 31, 2019 | -$14.73M | – |
| Q4 FY2018 | Dec 31, 2018 | -$7.31M | – |
| Q3 FY2018 | Sep 30, 2018 | -$5.59M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.42M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.72M | – |
See a number that looks wrong?